Asymmetry Capital Management

Asymmetry Capital Management as of June 30, 2021

Portfolio Holdings for Asymmetry Capital Management

Asymmetry Capital Management holds 30 positions in its portfolio as reported in the June 2021 quarterly 13F filing

Company (Ticker) Portfolio Weight Valued At Change in Shares Share Count Share Price
Centene Corporation (CNC) 8.2 $12M 165k 72.93
Astrazeneca Plc-spons Adr (AZN) 7.2 $11M 176k 59.90
Sotera Health (SHC) 7.0 $10M 421k 24.23
Arena Pharmaceuticals 6.7 $9.7M 142k 68.20
Mirati Therapeutics 6.4 $9.4M 58k 161.52
Jazz Pharmaceuticals (JAZZ) 6.4 $9.4M 53k 177.64
Insulet Corporation (PODD) 5.5 $7.9M 29k 274.51
Alkermes (ALKS) 5.1 $7.5M 305k 24.52
Adaptive Biotechnologies Cor (ADPT) 4.7 $6.9M 168k 40.86
Essa Pharma (EPIX) 4.2 $6.1M 213k 28.57
Kymera Therapeutics (KYMR) 4.1 $6.0M 123k 48.50
Aclaris Therapeutics (ACRS) 3.8 $5.5M 316k 17.56
Mereo Biopharma Group Pl- Adr (MREO) 3.5 $5.1M 1.6M 3.17
Biodesix (BDSX) 3.5 $5.0M 381k 13.21
Aslan Pharmaceuticals Lt- Adr 2.7 $3.9M 1.2M 3.30
Pmv Pharmaceuticals (PMVP) 2.4 $3.5M 102k 34.16
Hologic (HOLX) 2.1 $3.1M 46k 66.71
Guardant Health (GH) 2.1 $3.0M 24k 124.21
Amicus Therapeutics (FOLD) 2.0 $2.9M 299k 9.64
Avadel Pharmaceuticals Adr (AVDL) 1.8 $2.7M 400k 6.73
Argenx Se - Adr (ARGX) 1.7 $2.4M 8.1k 301.09
Forte Biosciences (FBRX) 1.5 $2.2M 66k 33.62
Bio-Rad Laboratories (BIO) 1.3 $1.9M 3.0k 644.18
Iteos Therapeutics (ITOS) 1.1 $1.6M 61k 25.65
Graphite Bio 1.1 $1.6M 51k 30.72
Seres Therapeutics (MCRB) 1.0 $1.5M 63k 23.85
Verve Therapeutics (VERV) 1.0 $1.5M 25k 60.27
Regulus Therapeutics 0.8 $1.2M 1.5M 0.81
Bcls Acquisition Corp 0.6 $877k 83k 10.53
Galecto (GLTO) 0.2 $308k 61k 5.05